TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32372182

Group type: EXPERIMENTAL
Intervention: Lumboperitoneal shunt (LPS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 78
Study: 35575453

Group type: EXPERIMENTAL
Intervention: Elastic band resistance training
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Training with nutritional supplementation
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 33470653

Group type: EXPERIMENTAL
Intervention: Nipple-sparing mastectomy (NSM)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: NSM combined with reconstructive surgery
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Curvilinear incision
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Circumareolar incision
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Tumor-to-nipple distance (TND)
Number of subjects: 615
Study: 32307004

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg/kg every 6 hours for a total of four doses, started 6 to 12 hours prior to extubation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study: 34625209

Group type: EXPERIMENTAL
Intervention: Once‐weekly oral practice session
Number of subjects: 530

Group type: COMPARATOR
Intervention: No follow‐up support
Number of subjects: 530
Study: 32957926

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg/kg in 100 ml of isotonic saline over 15 min before anesthesia induction and then 15 mg/kg per hour by continuous intravenous infusion (Group M)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Isotonic saline as placebo (Group C)
Number of subjects: 70
Study: 34882500

Group type: EXPERIMENTAL
Intervention: 150 mg once daily bupropion
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 300 mg once daily bupropion
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 33147721

Group type: EXPERIMENTAL
Intervention: Health Improvement Card (HIC) intervention group
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study: 36048358

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 110

Group type: COMPARATOR
Intervention: Clopidogrel (baseline)
Number of subjects: 110
Study: 35078153

Group type: EXPERIMENTAL
Intervention: VR mental training group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Conventional mental training group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 33004126

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 1858

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: PMIProt
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: PMIUD
Number of subjects: 1858
Study: 35803552

Group type: EXPERIMENTAL
Intervention: Pharmacomechanical catheter-directed thrombolysis (PCDT)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Anticoagulation alone
Number of subjects: 381
Study: 32854984

Group type: EXPERIMENTAL
Intervention: Nudge Leaflet group
Number of subjects: 418

Group type: COMPARATOR
Intervention: Standard Care Leaflet group
Number of subjects: 418

Group type: COMPARATOR
Intervention: Neutral Leaflet group
Number of subjects: 418
Study: 37330725

Group type: EXPERIMENTAL
Intervention: DLP group (aged samples)
Number of subjects: 80

Group type: COMPARATOR
Intervention: SLA group (aged samples)
Number of subjects: 80

Group type: COMPARATOR
Intervention: SLA control group
Number of subjects: 80

Group type: COMPARATOR
Intervention: DLP control group
Number of subjects: 80
Study: 34782535

Group type: EXPERIMENTAL
Intervention: Endometrial thickness (ET) measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EG-VEGF expression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subendometrial resistivity index and PI
Number of subjects: 0
Study: 32093689

Group type: EXPERIMENTAL
Intervention: Nomadic pastoralists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed farmers
Number of subjects: 0
Study: 33678437

Group type: EXPERIMENTAL
Intervention: Interocclusal devices of 3- and 6-mm thickness for 24 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interocclusal devices of 6-mm thickness
Number of subjects: 20
Study: 33504161

Group type: EXPERIMENTAL
Intervention: Guaranteed $10 incentive
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Lottery for $50 incentive
Number of subjects: 37

Group type: COMPARATOR
Intervention: No incentive recall
Number of subjects: 37
Study: 32475050

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with achieved systolic blood pressure (SBP) measurements
Number of subjects: 2048

Group type: EXPERIMENTAL
Intervention: Higher achieved SBP
Number of subjects: 2048

Group type: EXPERIMENTAL
Intervention: Achieved BP during follow-up
Number of subjects: 2048
Study: 35970199

Group type: EXPERIMENTAL
Intervention: Placement of intrauterine device within 48 hours after abortion
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placement of intrauterine device at 2 to 4 weeks after abortion
Number of subjects: 240
Study: 33826814

Group type: EXPERIMENTAL
Intervention: Microbiota-directed complementary food prototype (MDCF-2)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Ready-to-use supplementary food (RUSF)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: MDCF-2
Number of subjects: 123
Study: 35614144

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) - 3 sessions of 60-min Yang-style Tai Chi training per week for 24 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Conventional exercise (EX) - 3 sessions of 60-min fitness training per week for 24 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (CON) - no intervention
Number of subjects: 34
Study: 34228273

Group type: COMPARATOR
Intervention: Strength Training (ST)
Number of subjects: 59

Group type: COMPARATOR
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: HIIT + Strength Training (HIIT + ST)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 59
Study: 35496380

Group type: EXPERIMENTAL
Intervention: Standard titration for the first 6 days
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: All tablets in a starter pack once a day for 13 days
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Two starter packs as 8 tablets each of apremilast 10 mg and 20 mg once a day and 10 tablets of 30 mg once a day for 26 days
Number of subjects: 128
Study: 33483444

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group without treatment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 120
Study: 35526164

Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo-control (0.9% saline)
Number of subjects: 12
Study: 33092327

Group type: EXPERIMENTAL
Intervention: Pilates exercises (16 sessions, 60 minutes each, twice a week for 8 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 78
Study: 32335356

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus curcumin (CUC-1®, 300 mg solution, once per week)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Paclitaxel plus placebo
Number of subjects: 150
Study: 35285922

Group type: EXPERIMENTAL
Intervention: Intensive treatment group (systolic BP target < 120 mm Hg)
Number of subjects: 9342

Group type: COMPARATOR
Intervention: Standard treatment group (systolic BP target < 140 mm Hg)
Number of subjects: 9342

Group type: EXPERIMENTAL
Intervention: Intensive treatment group
Number of subjects: 9342

Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 9342
Study: 32602450

Group type: EXPERIMENTAL
Intervention: Recovery group based on the Pathways to Recovery program, 1-hour session once a week for 18 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Recovery group based on the Pathways to Recovery program
Number of subjects: 24
Study: 36122531

Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel (≤12 mg/day)
Number of subjects: 309
Study: 34663363

Group type: EXPERIMENTAL
Intervention: Betaine (BG, 2 g/day; n=14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (PG, n=15)
Number of subjects: 29
Study: 33191526

Group type: EXPERIMENTAL
Intervention: Highlighting patterns during reading
Number of subjects: 400
Study: 36036746

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 476

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study: 32810039

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Ledipasvir (SOF/LDV) 400/90 mg once daily ± ribavirin
Number of subjects: 78
Study: 35987770

Group type: EXPERIMENTAL
Intervention: Chopstick technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cross technique
Number of subjects: 0
Study: 33136089

Group type: EXPERIMENTAL
Intervention: Elastic tape
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 40
Study: 32963638

Group type: EXPERIMENTAL
Intervention: Incentive spirometer exercise combined with inspiratory muscle training (study group, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Incentive spirometer exercise (control group, n=20)
Number of subjects: 40
Study: 33387000

Group type: EXPERIMENTAL
Intervention: Dual-task cough testing (simultaneous tone counting)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Single-task cough testing (cough testing only)
Number of subjects: 14
Study: 32911733

Group type: EXPERIMENTAL
Intervention: Foot exercises daily for six weeks (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No intervention (Group 2)
Number of subjects: 80
Study: 36153251

Group type: EXPERIMENTAL
Intervention: Hybrid Model (HM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-Person (IP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Remote Learning (RL)
Number of subjects: 0
Study: 34577838

Group type: EXPERIMENTAL
Intervention: Auto-CPAP with SensAwake (SA) on
Number of subjects: 25

Group type: COMPARATOR
Intervention: Auto-CPAP without SensAwake (SA) off
Number of subjects: 25
Study: 32781940

Group type: EXPERIMENTAL
Intervention: l-NMMA (6 mg/kg, iv over 5 minutes)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36093154

Group type: EXPERIMENTAL
Intervention: HL‐RT + AT (70–80% of 1‐RM)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: LL‐RT + AT (35–40% of 1‐RM)
Number of subjects: 79

Group type: COMPARATOR
Intervention: AT (control group)
Number of subjects: 79
Study: 33211152

Group type: EXPERIMENTAL
Intervention: Higher dosage of oral spermidine supplementation
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Lower dosage of oral spermidine supplementation
Number of subjects: 85
Study: 35753857

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No VR
Number of subjects: 65
Study: 34197181

Group type: EXPERIMENTAL
Intervention: Docetaxel (60 mg/m2 once every 3 weeks for three cycles before RT and 20 mg/m2 once weekly during RT)
Number of subjects: 350
Study: 32782729

Group type: EXPERIMENTAL
Intervention: Methadone (5 mg/ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tincture of Opium (TOP) (10 mg/ml)
Number of subjects: 60
Study: 33954888

Group type: EXPERIMENTAL
Intervention: Home hospital care (including nurse and physician home visits, intravenous medications, remote monitoring, video communication, and point‐of‐care testing)
Number of subjects: 248
Study: 34254256

Group type: EXPERIMENTAL
Intervention: High-dose intravenous iron (400 mg/week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose intravenous iron (100 mg/week)
Number of subjects: 60
Study: 32051009

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with kinesiotape (AcuKT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between AcuKT and acupuncture
Number of subjects: 60
Study: 32939546

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (adenovirus serotype 26)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo (modified vaccinia Ankara)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Booster vaccination (Ad26 or MVA) on day 360
Number of subjects: 164

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 164
Study: 33993702

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No Candesartan
Number of subjects: 120

Group type: COMPARATOR
Intervention: No Metoprolol
Number of subjects: 120
Study: 32633801

Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB‐12, total cell count per capsule, 1.3 × 10^10 to 1.6 × 10^10)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo group (matched placebo)
Number of subjects: 310
Study: 35681717

Group type: EXPERIMENTAL
Intervention: Immediate community-based exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed community-based exercise
Number of subjects: 80
Study: 34014113

Group type: EXPERIMENTAL
Intervention: Didactic Intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ACCENT intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 32535161

Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Inclusion of Seminal Vesicles (SV) in PTV
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Overall Protocol Deviations
Number of subjects: 165
Study: 35087138

Group type: EXPERIMENTAL
Intervention: 10-Hz rTMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anodal 2 mA tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham (control)
Number of subjects: 20
Study: 33894592

Group type: EXPERIMENTAL
Intervention: Postgraduate course in clinical assessment
Number of subjects: 85

Group type: COMPARATOR
Intervention: No postgraduate course (Control)
Number of subjects: 85
Study: 35288818

Group type: EXPERIMENTAL
Intervention: Group A (booklet)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Group AB (booklet and video)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Group B (video)
Number of subjects: 241
Study: 33218747

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 75
Study: 32763873

Group type: EXPERIMENTAL
Intervention: Mobile Phone Automated System (MPAS)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Paper and Email Data Collection (PEDC)
Number of subjects: 555
Study: 36036175

Group type: EXPERIMENTAL
Intervention: Stroke ICF‐CS based occupational therapy (two months, three sessions per week, 45 minutes each session)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Traditional occupational therapy (control group)
Number of subjects: 25
Study: 32951157

Group type: EXPERIMENTAL
Intervention: Participants with autism spectrum disorder (ASD)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Typically developing (TD) controls
Number of subjects: 121
Study: 35274356

Group type: EXPERIMENTAL
Intervention: Hybrid closed‐loop insulin delivery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sensor‐augmented pump therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Remote monitoring technology
Number of subjects: 30
Study: 33822015

Group type: EXPERIMENTAL
Intervention: CYD-TDV (tetravalent dengue vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32106780

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy-derived total haemoglobin ([tHb])
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SmO2 reperfusion slope (SmO2_slope)
Number of subjects: 12
Study: 35201949

Group type: EXPERIMENTAL
Intervention: Baseline Human Body Model (HBM)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Personalized Human Body Model (HBM)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Post mortem human subjects (PMHS) tests
Number of subjects: 3
Study: 33413075

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg)
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (225 mg)
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Fremanezumab
Number of subjects: 857
Study: 33345890

Group type: EXPERIMENTAL
Intervention: Intraamniotic infection
Number of subjects: 2241

Group type: COMPARATOR
Intervention: Clinical chorioamnionitis
Number of subjects: 2241
Study: 35902075

Group type: EXPERIMENTAL
Intervention: Aquatic aerobic training (AERO)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Aquatic combined training (COMBI)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Aquatic active procedure control
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 57
Study: 32621555

Group type: EXPERIMENTAL
Intervention: Climate intervention (12 x 40-minute lessons)
Number of subjects: 2190

Group type: EXPERIMENTAL
Intervention: Preventure intervention (2 x 90-minute sessions)
Number of subjects: 2190

Group type: EXPERIMENTAL
Intervention: Combined prevention (CAP)
Number of subjects: 2190

Group type: COMPARATOR
Intervention: Health education as usual (control)
Number of subjects: 2190
Study: 33155562

Group type: EXPERIMENTAL
Intervention: Boss-Holzach-Matter (BHM) technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spaso (Sp) method
Number of subjects: 60
Study: 34061693

Group type: COMPARATOR
Intervention: E-mails emphasizing public health values (PH values) without the word abortion
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: E-mails using the word abortion
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Both groups (PH values and abortion messaging)
Number of subjects: 302
Study: 34326283

Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Darunavir
Number of subjects: 222
Study: 32520991

Group type: EXPERIMENTAL
Intervention: l-serine (594 mg daily) and EPA (149 mg daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: l-serine and EPA
Number of subjects: 120
Study: 35984848

Group type: EXPERIMENTAL
Intervention: Reduced load (80% body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal load (100% body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased load (120% body weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33341518

Group type: EXPERIMENTAL
Intervention: Self-applied tape
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SEP-applied tape
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (no tape)
Number of subjects: 53
Study: 32920802

Group type: EXPERIMENTAL
Intervention: Activated cooling vest
Number of subjects: 20

Group type: COMPARATOR
Intervention: Deactivated cooling system (control)
Number of subjects: 20
Study: 32678781

Group type: EXPERIMENTAL
Intervention: Cognitive fit present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive fit not present
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjective measure (NASA task load index)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Performance measures (response time and accuracy)
Number of subjects: 0
Study: 36014827

Group type: EXPERIMENTAL
Intervention: liposomal MVM
Number of subjects: 25

Group type: COMPARATOR
Intervention: standard MVM
Number of subjects: 25
Study: 33392636

Group type: EXPERIMENTAL
Intervention: Early apixaban therapy
Number of subjects: 100
Study: 33276145

Group type: EXPERIMENTAL
Intervention: Self-control treatment group (7-week smartphone-based self-control intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention, only tracking physical activity)
Number of subjects: 0
Study: 34791768

Group type: EXPERIMENTAL
Intervention: FAM-SOTC intervention (n=29)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (n=32)
Number of subjects: 72
Study: 33393708

Group type: EXPERIMENTAL
Intervention: Written sun safety policy
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Unwritten standard procedures on sun protection
Number of subjects: 1113
Study: 33483173

Group type: EXPERIMENTAL
Intervention: LTH + G advertisements
Number of subjects: 1156

Group type: EXPERIMENTAL
Intervention: LTH advertisements
Number of subjects: 1156

Group type: COMPARATOR
Intervention: NON-ALC advertisements
Number of subjects: 1156
Study: 32453288

Group type: EXPERIMENTAL
Intervention: cherry extract 3,600 mg/d
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: dietitian-assisted diet modification
Number of subjects: 84
Study: 36200434

Group type: EXPERIMENTAL
Intervention: B6 program
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control comparison program
Number of subjects: 71
Study: 33783013

Group type: EXPERIMENTAL
Intervention: Nuffield Early Language Intervention (NELI) programme
Number of subjects: 5879

Group type: COMPARATOR
Intervention: Business-as-usual control group
Number of subjects: 5879
Study: 32712899

Group type: EXPERIMENTAL
Intervention: Fractionation-guided ablation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cavotricuspid isthmus ablation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cardioversion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall arrhythmia-free survival
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Procedural failure
Number of subjects: 12
Study: 36018733

Group type: EXPERIMENTAL
Intervention: Skin adhesive with underlying adhesive strips
Number of subjects: 120

Group type: COMPARATOR
Intervention: Skin adhesive alone
Number of subjects: 120
Study: 33561143

Group type: EXPERIMENTAL
Intervention: PrEP initiators
Number of subjects: 5447

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 5447

Group type: EXPERIMENTAL
Intervention: PrEP initiators (women)
Number of subjects: 5447

Group type: EXPERIMENTAL
Intervention: PrEP initiators (men)
Number of subjects: 5447